Literature DB >> 2387254

Calcium-dependent protein kinase activity is decreased in diabetic rat sciatic nerve.

R A Gabbay1, L Siconolfi-Baez, H E Lebovitz.   

Abstract

The effects of 4 weeks of streptozotocin-induced diabetes in the rat on sciatic nerve homogenate protein kinase activities were studied. There was a 47 +/- 7% inhibition of Ca+2-dependent protein kinase activity in nerves from the diabetic rats compared to that in their paired normal controls. This Ca+2-dependent activity did not require the addition of phospholipid and was only minimally affected by Sephadex G-50 gel filtration, suggesting that endogenous phospholipid activation was not responsible for this activity. The addition of phospholipid in the presence of Ca+2 revealed an additional activity in these homogenates which probably represents the Ca+2-phospholipid-dependent protein kinase (protein kinase-C). The diabetic state did not appear to alter that activity. The Ca+2-dependent protein kinase was sensitive to agents known to inhibit calmodulin-dependent protein kinase or protein kinase-C. The IC50 values of the inhibitors for the Ca+2-dependent protein kinase, however, differed from those reported for the other two kinases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2387254     DOI: 10.1210/endo-127-3-1194

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  3 in total

Review 1.  The role of axonal cytoskeleton in diabetic neuropathy.

Authors:  W G McLean
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

2.  Posttranslational modifications of nerve cytoskeletal proteins in experimental diabetes.

Authors:  W G McLean; C Pekiner; N A Cullum; I F Casson
Journal:  Mol Neurobiol       Date:  1992 Summer-Fall       Impact factor: 5.590

3.  The effects of dietary treatment with essential fatty acids on sciatic nerve conduction and activity of the Na+/K+ pump in streptozotocin-diabetic rats.

Authors:  M J Lockett; D R Tomlinson
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.